Literature DB >> 24743803

[Establishment of drug resistant cell line of MGC-803 and analysis of differential secretome].

Hao Huang1, Yong Han1, Jian Wu1, Zhi-hua Tian1, Li-ke Qu1, Cheng-chao Shou1.   

Abstract

OBJECTIVE: To identify chemoresistance-associated secretory proteins by proteomic approaches, and to provide the basis for selecting suitable chemotherapy in gastric cancer treatment.
METHODS: Drug resistant cell lines were established by gradient drug treatment with MGC-803 gastric cancer cells. The secreted proteins of MGC-803 parental and resistant cells were collected from the conditional medium without serum and separated by two-dimensional gel electrophoresis (2-DE).The proteins were analyzed by PD Quest 7.1.0 software and identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Real-time RT-PCR was performed to confirm the difference of expression on the mRNA level.
RESULTS: The 5-fluorouracil (5FU), paclitaxel (TA) and cisplatin (DDP)-resistant gastric cancer cell lines with the resistance indexes of 110.6, 70.0 and 13.3 respectively, were established successfully. DDP-resistant cells had strong cross-resistance to 5FU and TA, and the resistance indexes were 23.5 and 114.0. 5FU-resistant cells also had strong cross-resistance to TA with the resistance index 70.0. The 2-DE patterns of protein component spectra from the conditional medium were obtained with 18 proteins whose abundances were increased in all chemoresistance cells for more than 2-fold, 13 of which were identified by mass spectrometry, including protease and proteins involved in signal transduction. Compared with the parental cell MGC-803, SLMAP, TOP3A, DYNC1H1, RHPN1, PUF60 and SIAH1 were significantly up-regulated in three drug resistant cells, IFT172 and FILIP were up-regulated in 5FU-resistant and TA-resistant cells, PLVAP and LMNA were up-regulated in TA- and DDP-resistant cells. Further validation revealed that SIAH1 protein was enriched in cell lysates and the conditional medium from all the drug resistant cells.
CONCLUSION: By establishing the 5FU-,TA- and DDP-resistant gastric cancer cell lines and assisted by 2-DE and mass spectrometry, we demonstrated the different secretory protein profiling and found that SIAH1 had significantly increased in both cell lysates and the conditional medium of the drug-resistant cells, which are potential candidates for developing chemoresistance markers in sera from gastric cancer patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743803

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  5 in total

1.  Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression.

Authors:  Ashok Palaniappan; Karthick Ramar; Satish Ramalingam
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

2.  Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.

Authors:  Jian Wu; Hongqiang Qin; Ting Li; Kai Cheng; Jiaqiang Dong; Miaomiao Tian; Na Chai; Hao Guo; Jinjing Li; Xin You; Mingming Dong; Mingliang Ye; Yongzhan Nie; Hanfa Zou; Daiming Fan
Journal:  Oncotarget       Date:  2016-05-03

3.  DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression.

Authors:  Li-Bao Gong; Ti Wen; Zhi Li; Xing Xin; Xiao-Fang Che; Jin Wang; Yun-Peng Liu; Xiu-Juan Qu
Journal:  Front Oncol       Date:  2019-06-12       Impact factor: 6.244

4.  Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.

Authors:  Dongsheng Huang; Hongying Duan; Hao Huang; Xiangmin Tong; Yong Han; Guoqing Ru; Like Qu; Chengchao Shou; Zhongsheng Zhao
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

5.  Association of DYNC1H1 gene SNP/CNV with disease susceptibility, GCs efficacy, HRQOL, anxiety, and depression in Chinese SLE patients.

Authors:  Shunwei Huang; Tingyu Zhang; Yuhua Wang; Linlin Wang; Ziye Yan; Ying Teng; Zhen Li; Qiuyue Lou; Shuang Liu; Jing Cai; Yangfan Chen; Mu Li; Hailiang Huang; Zhouzhou Xu; Yanfeng Zou
Journal:  J Clin Lab Anal       Date:  2021-07-17       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.